Food for thought about drug presentations
If a drug company treats a doctor to a nice lunch and a presentation on their newest products, is prescribing affected?
Doctors generally think not, but the research evidence overwhelmingly says yes. And if these events do affect doctors’ decisions on patient care, should we be worried?
An exposé last week described over A$43